Public misperceptions of COVID-19 vaccine effectiveness and waning: experimental evidence from Ireland

被引:6
|
作者
Lunn, P. D. [1 ]
Timmons, S. [2 ]
机构
[1] Trinity Coll Dublin, Econ & Social Res Inst, Dept Econ, ESRI,Whitaker Sq,Sir John Rogersons Quay, Dublin, Ireland
[2] Trinity Coll Dublin, Econ & Social Res Inst, Dept Psychol, Dublin, Ireland
关键词
COVID-19; Vaccination; Vaccine effectiveness; Vaccine hesitancy; Public perception; Introduction;
D O I
10.1016/j.puhe.2022.11.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives: The study set out to measure public understanding of COVID-19 vaccine effectiveness (VE) and how effectiveness wanes with time since vaccination. Because perceived VE is a strong predictor of vaccine uptake, measuring perceptions can inform public health policy and communications. Study design: Online randomised experiment. Methods: The study was undertaken in Ireland, which has high vaccination rates. A nationally representative sample (n = 2000) responded to a scenario designed to measure perceptions of COVID-19 VE against mortality. The length of time since vaccination in the scenario was randomly varied across four treatment arms (2 weeks, 3 months, 6 months, and 9 months). Results: The public underestimates VE, with substantial variation in perceptions. A majority (57%) gave responses implying perceived VE against mortality of 0-85%, i.e., below scientific estimates. Among this group, mean perceived VE was just 49%. Over a quarter (26%) gave responses implying perceived VE greater than 95%, i.e., above scientific estimates. Comparing the four treatment groups, responses took no account of vaccine waning. Perceived VE was actually higher 9 months after vaccination than 2 weeks after vaccination. Conclusion: Despite high vaccination rates, most of the public in Ireland underestimates VE. Furthermore, the general public has not absorbed the concept of vaccine waning in the months following vaccination. Both misperceptions may reduce vaccine uptake, unless public health authorities act to correct them through improved communication. (c) 2022 The Authors. Published by Elsevier Ltd on behalf of The Royal Society for Public Health. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:81 / 84
页数:4
相关论文
共 50 条
  • [41] Vaccine effectiveness of COVID-19 and rebound in the real world
    Park, Myung-Bae
    Sim, Boram
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4975 - 4983
  • [42] Impact of BMI on COVID-19 vaccine effectiveness Comment
    Wilder-Smith, Annelies
    Frahsa, Annika
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (08): : 551 - 552
  • [43] Effectiveness of mRNA Covid-19 vaccine in healthcare workers
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (05): : 284 - 284
  • [44] Covid-19 Vaccine Effectiveness in New York State
    Rosenberg, Eli S.
    Dorabawila, Vajeera
    Easton, Delia
    Bauer, Ursula E.
    Kumar, Jessica
    Hoen, Rebecca
    Hoefer, Dina
    Wu, Meng
    Lutterloh, Emily
    Conroy, Mary Beth
    Greene, Danielle
    Zucker, Howard A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (02): : 116 - 127
  • [45] COVID-19 vaccine effectiveness in patients with hematologic malignancy
    Shah, Dimpy P.
    Shah, Pankil K.
    Thompson, Michael A.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [46] Evidence-based policies in public health to address COVID-19 vaccine hesitancy
    Chirico, Francesco
    Teixeira da Silva, Jaime A.
    [J]. FUTURE VIROLOGY, 2023, 18 (04) : 261 - 273
  • [47] Effect of the COVID-19 vaccine on preventive behaviors: Evidence from Japan
    Yamamura, Eiji
    Kosaka, Youki
    Tsutsui, Yoshiro
    Ohtake, Fumio
    [J]. arXiv, 2022,
  • [48] Relevance of COVID-19 vaccine on the tourism industry: Evidence from China
    Agyeman, Fredrick Oteng
    Ma, Zhiqiang
    Li, Mingxing
    Sampene, Agyemang Kwasi
    Adikah, Israel
    Dapaah, Malcom Frimpong
    [J]. PLOS ONE, 2022, 17 (08):
  • [49] Lack of evidence for BCG vaccine protection from severe COVID-19
    Arlehamn, Cecilia S. Lindestam
    Sette, Alessandro
    Peters, Bjoern
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (41) : 25203 - 25204
  • [50] Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness
    Lind, Margaret L.
    Copin, Richard
    McCarthy, Shane
    Coppi, Andreas
    Warner, Fred
    Ferguson, David
    Duckwall, Chelsea
    Borg, Ryan
    Muenker, M. Catherine
    Overton, John
    Hamon, Sara
    Zhou, Anbo
    Cummings, Derek A. T.
    Ko, Albert, I
    Hamilton, Jennifer D.
    Schulz, Wade
    Hitchings, Matt D. T.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (05): : 663 - 674